Calcium sparklets-induced vascular dysfunction during diabetes
糖尿病期间钙火花诱导的血管功能障碍
基本信息
- 批准号:7982925
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-19 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:A kinase anchoring proteinAcuteAffectAmericanArteriesArtsBiologicalBlood PressureBlood VesselsCalciumCardiovascular systemCellsContractile ProteinsCyclic AMP-Dependent Protein KinasesDataDevelopmentDiabetes MellitusDihydropyridinesDiseaseElectrophysiology (science)EventFigs - dietaryFunctional disorderGene ExpressionGoalsHyperglycemiaHypertensionImageL-Type Calcium ChannelsMembraneMetabolicModalityModelingMolecularMolecular ModelsMorbidity - disease rateMuscleMuscle CellsNon-Insulin-Dependent Diabetes MellitusOpticsOutcomePathway interactionsPhosphotransferasesPhysiologicalPlayPotassiumPotassium ChannelRegulationReportingResearch Project GrantsResistanceRoleScaffolding ProteinSeriesSignal TransductionSiteSmooth MuscleStrokeSystemTechniquesTelemetryTestingVascular Smooth MuscleWorkbaseconstrictiondiabeticdihydropyridineinnovationmodel developmentmolecular imagingmolecular modelingmortalitynovelpublic health relevanceresearch studytranscription factortranscription factor NF-AT c3voltage
项目摘要
DESCRIPTION (provided by applicant): Calcium influx via dihydropyridine-sensitive, voltage-gated L-type calcium channels (LTCC) plays a crucial role in the regulation of excitability, contraction, and gene expression in arterial smooth muscle. Exaggerated Ca2+ influx through smooth muscle LTCCs has been implicated in the chain of events contributing to hyperglycemia- induced vascular dysfunction during non-insulin dependent diabetes mellitus (NIDDM). However, the molecular mechanisms underlying the increase in LTCC activity during hyperglycemia and NIDDM remain poorly defined. Recently, we identified and characterized a novel modality of LTCC function in which a single or a small cluster of these channels can operate in a persistent gating mode that create sites of nearly continual Ca2+ influx (called "persistent Ca2+ sparklets") in arterial myocytes. Under physiological conditions, persistent Ca2+ sparklet activity is low. However, preliminary data presented in this application suggest that Ca2+ sparklet activity increases during hyperglycemia and NIDDM through a mechanism requiring protein kinase A (PKA) activation and membrane targeting of this kinase by the scaffolding protein AKAP150. The goal of this application is to test the central hypothesis that an increase in persistent Ca2+ sparklet activity is an early, critical event in the pathway leading to vascular dysfunction during diabetes. The central hypothesis has been formulated on the basis of strong preliminary data and will be tested by pursuing three novel specific aims. Aim 1 will investigate the mechanisms and functional consequences of increased Ca2+ sparklet activity in arterial smooth muscle during hyperglycemia and diabetes. Aim 2 will determine the role of AKAP150 and PKA activity in the mechanisms leading to increase Ca2+ sparklet activity during acute hyperglycemia and diabetes. Aim 3 will test the hypothesis that persistent Ca2+ sparklets downregulate K+ channel expression through the activation of NFATc3 during acute hyperglycemia and diabetes. These hypotheses will be tested using a series of novel imaging approaches developed by our team in combination with state-of-the-art electrophysiological, cellular, and molecular biological approaches. The proposed work is innovative as it aims to integrate, at multiple levels, the mechanisms contributing to vascular dysfunction during NIDDM. Such outcomes will be significant because they will provide new fundamental information on the mechanisms by which increased Ca2+ sparklet activity underlie vascular dysfunction during NIDDM and may contribute to the development of rational therapies for the treatment of this pathological condition.
PUBLIC HEALTH RELEVANCE: Approximately 10 million Americans suffer of non-insulin dependent diabetes, which, if untreated, leads to several cardiovascular complications such as hypertension and strokes. This research project will determine the mechanisms by which hyperglycemia induces the activation of a novel Ca2+ signaling modality (e.g. persistent Ca2+ sparklets) in the muscle cells of blood vessels, causing increased contraction and thereby leading to arterial dysfunction during diabetes.
描述(由申请人提供):通过二氢吡啶敏感性电压门控L型钙通道(LTCC)的钙内流在动脉平滑肌兴奋性、收缩和基因表达的调节中起着至关重要的作用。在非胰岛素依赖型糖尿病(NIDDM)期间,通过平滑肌LTCC的过度Ca 2+内流涉及促成高血糖诱导的血管功能障碍的事件链。然而,在高血糖和NIDDM期间LTCC活性增加的分子机制仍然不清楚。最近,我们确定并表征了一种新的LTCC功能模式,其中单个或一小簇这些通道可以以持续门控模式操作,在动脉肌细胞中产生几乎连续的Ca 2+内流(称为“持续Ca 2+火花”)。在生理条件下,持续的Ca 2+火花活性低。然而,本申请中提供的初步数据表明,在高血糖症和NIDDM期间,Ca 2+火花活性通过需要蛋白激酶A(PKA)活化和支架蛋白AKAP 150对该激酶的膜靶向的机制而增加。本申请的目的是检验中心假设,即持续Ca 2+火花活性的增加是糖尿病期间导致血管功能障碍的途径中的早期关键事件。中心假设是在强有力的初步数据的基础上提出的,并将通过追求三个新的具体目标进行检验。目的1探讨高血糖和糖尿病时动脉平滑肌Ca ~(2+)火花活性增加的机制和功能后果。目的2:探讨AKAP 150和PKA活性在急性高血糖和糖尿病时Ca 2+火花活性增加机制中的作用。目的3将验证在急性高血糖和糖尿病期间持续的Ca 2+火花通过激活NFATc 3下调K+通道表达的假设。这些假设将使用我们的团队开发的一系列新的成像方法与最先进的电生理学,细胞和分子生物学方法相结合进行测试。拟议的工作是创新的,因为它的目的是整合,在多个层面上,机制有助于血管功能障碍,在NIDDM。这样的结果将是重要的,因为它们将提供新的基本信息的机制,其中增加的Ca 2+火花活性的基础血管功能障碍在NIDDM和可能有助于发展合理的治疗方法,用于治疗这种病理条件。
公共卫生相关性:大约1000万美国人患有非胰岛素依赖型糖尿病,如果不治疗,会导致几种心血管并发症,如高血压和中风。该研究项目将确定高血糖症诱导血管肌细胞中新型Ca 2+信号传导模式(例如持续性Ca 2+火花)激活的机制,导致收缩增加,从而导致糖尿病期间的动脉功能障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manuel F Navedo其他文献
Manuel F Navedo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manuel F Navedo', 18)}}的其他基金
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
心力衰竭中心脏 b1AR/SERCA2 复合物的调节
- 批准号:
10641923 - 财政年份:2022
- 资助金额:
$ 39万 - 项目类别:
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
心力衰竭中心脏 b1AR/SERCA2 复合物的调节
- 批准号:
10539066 - 财政年份:2022
- 资助金额:
$ 39万 - 项目类别:
cAMP signaling in vascular smooth muscle in health and disease
健康和疾病状态下血管平滑肌中的 cAMP 信号传导
- 批准号:
10370716 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
cAMP signaling in vascular smooth muscle in health and disease
健康和疾病状态下血管平滑肌中的 cAMP 信号传导
- 批准号:
10532163 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
A single amino acid in CaV1.2 controls channel activity and arterial tone in hypertension
CaV1.2 中的单个氨基酸控制高血压中的通道活性和动脉张力
- 批准号:
10392387 - 财政年份:2019
- 资助金额:
$ 39万 - 项目类别:
Cerebral Vascular Smooth Muscle Dysfunction in Alzheimer's Disease
阿尔茨海默氏病的脑血管平滑肌功能障碍
- 批准号:
10488479 - 财政年份:2019
- 资助金额:
$ 39万 - 项目类别:
Coupling of Vascular Cav1.2 Channels In Health & Disease
健康中血管 Cav1.2 通道的耦合
- 批准号:
8960054 - 财政年份:2015
- 资助金额:
$ 39万 - 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
- 批准号:
10306953 - 财政年份:2015
- 资助金额:
$ 39万 - 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
- 批准号:
10613545 - 财政年份:2015
- 资助金额:
$ 39万 - 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
- 批准号:
10451644 - 财政年份:2015
- 资助金额:
$ 39万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Operating Grants